Article
Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC.
Clinical lung cancer - 1 Dec 2024
Leonetti Alessandro, Cervati Veronica, Minari Roberta, Scarlattei Maura, Verzè Michela, Peroni Marianna, Pluchino Monica, Bonatti Francesco, Perrone Fabiana, Mazzaschi Giulia, Cosenza Agnese, Gnetti Letizia, Bordi Paola, Ruffini Livia, Tiseo Marcello
Abstract excerpt
OBJECTIVES: Despite the outstanding results achieved by osimertinib for the treatment of advanced EGFR-mutated NSCLC, the development of resistance is almost inevitable. While molecular mechanism responsible for osimertinib resistance are being mostly revealed, the definition of predictive biomarkers is crucial in order to identify patients at higher risk of progression and optimize treatment strategy. MATERIALS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
